Home›Companies›Biotech & Pharma›Chitogen

Chitogen Inc.

Updated Oct 29, 2026·Latest SEC filing Dec 13, 2023·Suggest an edit

About Chitogen

Chitogen is a private company based in Plymouth, Minnesota. It has reported $2,106,650 raised in five offerings on Form D since November 2013. Its chief executive is Steve Muellerleile.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Not yetDec 13, 2023$0of $1.0M target0—EquityRule 506(b)Form D ↗
Not yetDec 16, 2022$0of $750K target0—EquityRule 506(b)Form D ↗
Aug 10, 2018Oct 9, 2018amended May 6, 2022$523,500fully sold13$40,269EquityRule 506(b)Form D/A ↗1 earlier filing
May 12, 2015May 29, 2015$35,000of $2.9M target1$35,000EquityRule 506(b)Form D ↗
Oct 31, 2013Nov 13, 2013amended Jul 2, 2014$1,548,150fully sold23$67,311EquityRule 506(b)Form D/A ↗1 earlier filing
Total, five offerings$2,106,650

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Chitogen's Form D filed Dec 13, 2023.

YZ
Yong Zhu
Director
SM
Steve Muellerleile
Chief Executive Officer
DE
Douglas Eayrs
Chief Financial Officer and director
JD
James Drake
Director
RL
Robert Levy
Director

Earlier filings also listed Albert Emola (executive officer and director, last listed Dec 2022), Donald Sturtevant (director, last listed May 2022), Thomas Ritter (executive officer, last listed May 2015) and Michael Reilly (executive officer and director, last listed May 2015).

Sources

  1. SECCHITOGEN INC Form D, filed Oct 9, 2018
  2. SECCHITOGEN INC Form D, filed Nov 13, 2013
  3. SECCHITOGEN INC filing history